Please assess the completion status of the following clinical trial:

Trial Title: A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 45 years, inclusive.~* In good health with no history of major medical conditions~* A total body weight ≥ 50 kg and a body mass index (BMI) of \> 18kg/m2.~Exclusion Criteria:~* Acute or chronic medical illness~* Positive for Human Immunodeficiency Virus, Hepatitis B or C~* Nose or nasopharynx abnormalities~* Abnormal lung function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- ALS-008176 (Type: EXPERIMENTAL): ALS-008176 drug substance for oral suspension
- vehicle alone (Type: PLACEBO_COMPARATOR): Vehicle alone

Based on this trial design, predict the completion outcome and termination type (if applicable).